HIV-1 progression in hepatitis-C-infected drug users

Comment

F Cainelli et al. Lancet. 2001.

. 2001 Apr 28;357(9265):1361; author reply 1363.

doi: 10.1016/S0140-6736(00)04481-0.

No abstract available

Comment on

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study.
Greub G, Ledergerber B, Battegay M, Grob P, Perrin L, Furrer H, Burgisser P, Erb P, Boggian K, Piffaretti JC, Hirschel B, Janin P, Francioli P, Flepp M, Telenti A. Greub G, et al. Lancet. 2000 Nov 25;356(9244):1800-5. doi: 10.1016/s0140-6736(00)03232-3. Lancet. 2000. PMID: 11117912 Clinical Trial.
Why should hepatitis C affect immune reconstitution in HIV-1-infected patients?
Graham CS, Koziel MJ. Graham CS, et al. Lancet. 2000 Dec 2;356(9245):1865-6. doi: 10.1016/S0140-6736(00)03251-7. Lancet. 2000. PMID: 11130376 No abstract available.